3940 Trust Way
Hayward, CA 94545
United States
510 780 0819
https://benitec.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 16
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Jerel A. Banks M.D., Ph.D. | Executive Chairman & CEO | 848,07k | N/A | 1975 |
Ms. Megan Joan Boston BComm, CA, Dip., GAICD | Executive Director | 439,17k | N/A | 1972 |
Dr. Michael Graham | Head of Discovery & Founding Scientist | 128,05k | N/A | N/A |
Dr. Claudia Kloth | Senior Vice President of Manufacturing | N/A | N/A | N/A |
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.
Benitec Biopharma Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.